ETHERIO GROUP’S LIFE SCIENCES DIVISION TO FOCUS ON UNIQUE NEEDS OF BIOPHARMACEUTICAL COMPANIES WITH CLINICAL-STAGE PRODUCTS
BOCA RATON, FL / ATLANTA, GA (March 25, 2021) – Etherio Group is pleased to announce its Life Sciences division (formerly Global Meetings & Incentives), one of four divisions under the Etherio Group umbrella of leading meeting, event and incentive providers. Helmed by President Eli Sananes, Etherio Life Sciences has grown beyond its core offerings focused on mid-size clients, satellite symposiums and full-blown conferences. With an expanded team and enhanced capabilities, Etherio Life Sciences now offers additional services and technology to early- and clinical-stage biopharmaceutical companies on the verge of bringing products to market.
“We have extensive experience working with clinical-stage biopharmaceuticals that benefit greatly from our knowledge and roadmap of how to best approach a product launch meeting,” says Sananes. “Whether it is a new hire, train-the-trainer or a product launch meeting, clients have additional concerns beyond the logistical planning. Successful events including timelines, budget development, hotel sourcing and contracting, risk mitigation and compliant engagement strategies. Partnering with a company that has an in-depth undertsanding of biopharmaceutical launch requirements, and how to best navigate the launch roadmap, is critical for a successful exceution.”
Over the last 14 years, working with dozens of early- to clinical-stage biopharmaceutical companies, GMI, now Etherio Life Sciences, has achieved a deep and broad expertise in the biopharma space. “We develop partnerships with our clients, to the point that we become the extension of their internal processes; this close partnership is needed to manage every aspect of their unique programs,” says Sananes. “The expanding entrepreneurial needs of a client ramping toward a launch requires an experienced, agile entrepreneurial partner that can both guide them through this process while maintaining the flexibility to pivot as needs and timelines shift.”
The new financial strength created by joining forces with Etherio Group’s other subsidiaries has allowed for greater investment in a wider range of technology and support to service the evolving needs of pharmaceutical and health care clients in an increasingly challenging business environment. This technology includes budget management tools, electronic signature and wireless check-in devices, mobile app technology and project management solutions to streamline operations and ensure program success while allowing clients to view real-time data. Combined with our knowledge of the regulatory environment, both domestically and abroad, as well as our keen focus on the individual needs of each client, we are uniquely positioned to provide this service advantage to more companies as they ramp-up and prepare to commercialize their products.
Sananas adds, “We believe that focusing on the needs of biopharmaceutical companies in clinical-stage and about-to-file NDAs is an industry-first, and Etherio Life Sciences will deliver meaningful value to this unique set of companies.”
About Etherio Group
Based in Boca Raton, Florida, Etherio Group is a leading meeting, event and incentive provider as well as a supplier of services and technology for travel management companies, advisors and professionals. Etherio Group companies include ABC Global Services, CCRA International, MeetingAdvice and Global Meetings & Incentives. The company operates hundreds of events annually for corporate, pharmaceutical and association clients in addition to working with over 11,000 travel agency locations covering 76 countries. Jointly the businesses provide over 24 million room nights to hotel partners globally. For more information, visit etheriogroup.com.
